Skip to main content

Table 3 Antimutagenicity testing of the pure compounds against the four S. typhimurium tester strains

From: The mutagenic and antimutagenic activity of Sutherlandia frutescens extracts and marker compounds

Compound

*conc. (%)

TA97a (-S9)

TA98 (+S9)

TA100 (+S9)

TA102 (-S9)

L-arginine

5

43.0 ± 0.9a

22.1 ± 8.4a

48.6 ± 2.5a

106.5 ± 1.0a

2.5

57.1 ± 2.0b

67.4 ± 3.7b

96.0 ± 1.1b

116.1 ± 0.7a

1

84.1 ± 1.8b

85.3 ± 3.6b

124.1 ± 2.4c

119.3 ± 0.6a

L-canavanine

5

(−) 101.9 ± 3.7a

25.1 ± 6.7a

38.9 ± 1.5a

101.1 ± 0.7a

2.5

(−) 120.6 ± 4.5a

64.8 ± 5.0b

56.7 ± 2.1b

116.2 ± 0.4a

1

(−) 138.2 ± 4.1a

80.1 ± 2.3b

92.2 ± 1.7c

125.9 ± 1.0a

D-pinitol

5

31.2 ± 8.8a

26.6 ± 7.3a

36.1 ± 1.8a

82.8 ± 3.5a

2.5

79.0 ± 6.8b

48.8 ± 6.5b

79.6 ± 1.8b

109.5 ± 4.6a

1

143.5 ± 16.6c

65.0 ± 10.3b

117.2 ± 3.0b

115.0 ± 5.3a

GABA

5

58.8 ± 3.4a

14.3 ± 7.9a

32.9 ± 2.1a

98.3 ± 1.0a

2.5

61.8 ± 2.5a

45.8 ± 5.1b

66.2 ± 2.5b

113.1 ± 0.9a

1

61.4 ± 1.4a

72.5 ± 3.0b

105.4 ± 1.5c

116.7 ± 0.4a

Positive control

Revertant counts

9-AA

2-AAF

AFB1

CHP

247 ± 3

358 ± 26

360 ± 3

681 ± 4

  1. Inhibition expressed as mean % inhibition ± STD of the positive control. All three mean % inhibitions of the pure compounds where compare at similar dilutions. The mM concentrations of the pure compounds (5%) were as follows: L-arginine [0.28 × 103 mM], L-canavanine [0.26x103mM], D-pinitol [0.25 × 103 mM] and GABA (gamma aminobutyric acid) [0.48x103mM]. *Note that GABA concentration is almost double that of the other three compounds. *This table also shows a dose-response increase of the antimutagenic activity of the compounds, where in most cases the highest concentration’s inhibition is more than double that of the lowest. The negative or minus (−) sign indicated co-mutagenicity of L-canavanine with 9-AA in the absence of S9 activation
  2. Abbreviations: 9-AA 9-aminoacradine, 2-AAF 2-acetamidofluorene, AFB 1 aflatoxin B1, CHP cumoyl hydroperoxide